Latest / Bloomberg Law / Mifepristone Appeals and Unseating a Federal Judge
Transcript
- 0:02Speaker 1: You're listening to the Bloomberg Law Podcast. Catch us weekdays
- 0:05Speaker 1: at ten pm Easter on Bloomberg dot Com, the iHeartRadio app,
- 0:09Speaker 1: and the Bloomberg Business App, or listen on demand wherever
- 0:12Speaker 1: you get your podcast.
- 0:16Speaker 2: Welcome to the Bloomberg Law Show. I'm Kimberly Robinson alongside
- 0:19Speaker 2: Lydia Wheeler. Jin Grasso is out.
- 0:21Speaker 3: This week ahead.
- 0:22Speaker 4: In this hour, we'll discuss the latest in the saga
- 0:24Speaker 4: to remove the oldest active federal judge from the bench.
- 0:27Speaker 2: But first we'll discuss the battle over the abortion miph
- 0:30Speaker 2: of pristone, which has worked its way up to the
- 0:32Speaker 2: US Supreme Court again. Joining us now to explain is
- 0:36Speaker 2: Laurie Chaydon, a senior staff attorney at the ACLU's Reproductive
- 0:39Speaker 2: Freedom Project. Lauri, thanks for joining.
- 0:41Speaker 5: Us, Thanks so much for having me.
- 0:44Speaker 2: So I wonder if you could remind listeners about how
- 0:47Speaker 2: this case got started, what does the drug do, who
- 0:50Speaker 2: is challenging it, and briefly, what's the gist of their claims.
- 0:55Speaker 5: So this medication is known as mithapristone, and it is
- 0:59Speaker 5: a drug has been safely and effectively used for more
- 1:05Speaker 5: than two decades by five million people in the United
- 1:08Speaker 5: States through five presidential administrations after it was initially approved
- 1:13Speaker 5: in two thousand. It is used for abortion care and
- 1:17Speaker 5: it is used in the treatment of miscarriage, and this
- 1:21Speaker 5: it has been on the shelves for decades. It is
- 1:24Speaker 5: an essential medication and again has been approved for a
- 1:28Speaker 5: quarter of a century. The lawsuit is being brought by
- 1:32Speaker 5: a group of anti abortion physicians and groups that brought
- 1:38Speaker 5: a lawsuit in Amarillo, Texas, apparently seeking to put this
- 1:43Speaker 5: case before Judge Matthew Kesmeric who has a history and
- 1:47Speaker 5: a record of anti abortion, ANTILGBT, anti civil rights rulings.
- 1:53Speaker 5: They filed the lawsuit about a year ago, and they
- 1:57Speaker 5: tried to make the arguments that going all the way
- 1:59Speaker 5: back to the initial approval of mifropristone in two thousand,
- 2:04Speaker 5: that the drug should be lifted from the market, claiming
- 2:08Speaker 5: based on nothing, based on no facts, based on a
- 2:12Speaker 5: distortion of the law and a distortion of science, that
- 2:16Speaker 5: the FDA had failed to adequately assess the safety of
- 2:20Speaker 5: the drugs. Again, keep in mind, this is a medication
- 2:23Speaker 5: that has been used safely and effectively for more than
- 2:28Speaker 5: two decades by five million people, and it is its
- 2:31Speaker 5: efficacy rate is more than ninety five percent, So.
- 2:36Speaker 4: Laurie, one question I have is a technical one that
- 2:39Speaker 4: concerns standing. You know this idea that the court can
- 2:43Speaker 4: only hear certain kinds of claims by injured parties. How
- 2:47Speaker 4: are the doctors in this lawsuit claiming they've been injured.
- 2:52Speaker 5: Well, that's a really good question because in fact, they
- 2:55Speaker 5: have really pluged no injury at all. They don't prescribe
- 3:00Speaker 5: this medication, they don't treat patients or abortion care, they
- 3:05Speaker 5: don't use this medication in treating patients. They've effectively taken
- 3:10Speaker 5: the position that they may know someone who at some
- 3:15Speaker 5: point had to treat a patient based on a complication
- 3:21Speaker 5: after the patient had taken michel pristone. Now keep in
- 3:24Speaker 5: mind that no drug is risk free, but this is
- 3:27Speaker 5: a drug with a record of safety that is exceedingly
- 3:31Speaker 5: safe based on these scientific studies that are before the FDA.
- 3:36Speaker 5: This drug has serious complications almost never, and I mean
- 3:41Speaker 5: it's safer than pilon all safer than viagra. But these
- 3:45Speaker 5: doctors have come to the court and they said, well,
- 3:48Speaker 5: if we had to see a patient who maybe came
- 3:51Speaker 5: to our emergency room because maybe they took this drug,
- 3:54Speaker 5: we might have to treat them, that that would injure us.
- 3:57Speaker 5: It would injure our conscience. It would injure us because
- 4:00Speaker 5: it would take away our ability to treat other patients. Now,
- 4:03Speaker 5: keep in mind, when you're talking about an emergency room,
- 4:07Speaker 5: they treat all comers, right, This is not you don't
- 4:09Speaker 5: just doctors. You and I don't rely on a doctor
- 4:12Speaker 5: in the emergency room when we get there and they say, oh, sorry,
- 4:16Speaker 5: I don't approve of you because you smoke, or you
- 4:19Speaker 5: weigh too much or whatever. These doctors are basically saying
- 4:22Speaker 5: that if they were forced to treat somebody in the
- 4:26Speaker 5: very rare instance where this drug, where there was a
- 4:29Speaker 5: complication based on this drug, that they would somehow be injured.
- 4:33Speaker 5: That's not standing. And that is to be very clear,
- 4:38Speaker 5: both the procedural the standing arguments in this case as
- 4:43Speaker 5: well as the merits have been roundly criticized across the
- 4:48Speaker 5: ideological spectrum. You can go to the most conservative jurists
- 4:52Speaker 5: and finds that they are critical of this effort to
- 4:55Speaker 5: claim that they're standing an injury under Article three of
- 4:59Speaker 5: the Constance to bring this case.
- 5:02Speaker 2: Well, Laurie, let's talk a little bit about the merits,
- 5:03Speaker 2: because there are a lot of moving parts here, and
- 5:05Speaker 2: I was wondering if you could sort of walk us
- 5:07Speaker 2: through the different challenges to the law and how much
- 5:10Speaker 2: they really change things on the ground. So it's hoping
- 5:13Speaker 2: to start with the original two thousand approval of mithipristone.
- 5:17Speaker 2: What are the challenges to it, and if the court
- 5:20Speaker 2: were to side with those challengers here, what would the
- 5:24Speaker 2: effects be on the ground.
- 5:27Speaker 5: So thank you, that's a really important question. So the
- 5:31Speaker 5: bottom line is is that the challengers claim that the
- 5:35Speaker 5: FDA rushed the approval of this and didn't rely on science.
- 5:42Speaker 6: Which is utterly false.
- 5:44Speaker 5: This was a drug that had been used being in
- 5:46Speaker 5: use overseas for years with again an extremely safe record
- 5:52Speaker 5: of use, and then in the United States it took
- 5:55Speaker 5: four years of review and consideration of the science or
- 6:00Speaker 5: the FDA approved the drug in two thousands, and what
- 6:04Speaker 5: these plaintiffs in this case are trying to argue is
- 6:07Speaker 5: that that wasn't adequate and that FDA didn't appropriately rely
- 6:12Speaker 5: on science, didn't appropriately approve this drug. And therefore, now
- 6:17Speaker 5: keep in mind the approval was in two thousand, now
- 6:20Speaker 5: in almost twenty twenty four, that drug should be removed
- 6:24Speaker 5: from the market. So This is unprecedented. Never before has
- 6:29Speaker 5: a federal court ordered the Food and Drug Administration to
- 6:32Speaker 5: remove approval of a drug, particularly not one with this
- 6:36Speaker 5: kind of record of use and that has been on
- 6:40Speaker 5: the market and used by so many for so long.
- 6:44Speaker 5: If the plaintiffs were to prevail on that request again,
- 6:47Speaker 5: it means that mithipristone would go off the market. This
- 6:51Speaker 5: is a drug that is used in most of the
- 6:54Speaker 5: abortions in this country. The majority of abortions here in
- 6:57Speaker 5: this country relies on the use of mitha pristone. And
- 7:00Speaker 5: what these plaintiffs are asking is that the court order
- 7:04Speaker 5: FDA to withdraw approval to take this drug off the market.
- 7:09Speaker 4: Weren't there some amendments to the regulations around mithipristone in
- 7:12Speaker 4: twenty sixteen and can you walk us through what those were?
- 7:16Speaker 5: Sure? So, I mean, as with any drug, obviously, science
- 7:20Speaker 5: changes involves pharmaceutical companies invest in innovation and development and
- 7:25Speaker 5: they find ways to make drugs more effective and safer.
- 7:29Speaker 5: And that is exactly what happened with Michel Priystone. So
- 7:32Speaker 5: in twenty sixteen, after the drug had already been on
- 7:35Speaker 5: the market for sixteen years and had been safely used
- 7:38Speaker 5: by so many there were some updates to the conditions
- 7:42Speaker 5: for use of this drug. So, for example, there had
- 7:48Speaker 5: been a restriction that said that it had to be
- 7:53Speaker 5: prescribed in a healthcare setting. It had to be prescribed
- 7:56Speaker 5: in a medical office or a hot at all, or
- 8:01Speaker 5: another kind of healthcare facility. So that meant that patients
- 8:04Speaker 5: had to come in person in order to pick up
- 8:06Speaker 5: their mythipriss down and in twenty twenty, so for many years,
- 8:11Speaker 5: medical organizations had been pushing the FDA to lift that requirement.
- 8:16Speaker 5: It was medically unnecessary patients or essentially having to travel
- 8:20Speaker 5: long distances just for the sole purpose of coming in
- 8:23Speaker 5: essentially to pick up their pill. And during the height
- 8:28Speaker 5: of the pandemic in twenty twenty, the acl YOU brought
- 8:31Speaker 5: a lawsuit on behalf of the American College of Obstetricians
- 8:35Speaker 5: and Gynecologists and other healthcare providers to get the FDA
- 8:40Speaker 5: to lift that restriction so that patients wouldn't have to
- 8:44Speaker 5: put themselves in their families at risk of compressing a
- 8:48Speaker 5: deadly virus during the pandemic for the sole purpose of
- 8:51Speaker 5: traveling to a healthcare facility to pick up the medications.
- 8:55Speaker 5: And when that happened, we got that injunction of court
- 8:58Speaker 5: said that was okay. We ended up with lots of data,
- 9:02Speaker 5: lots of experience to show and demonstrate the safety of
- 9:06Speaker 5: patients being able to have this medication mailed to them
- 9:10Speaker 5: in their homes so that they could take it wherever
- 9:13Speaker 5: was safest and best for them. And as a result
- 9:16Speaker 5: of that and other data that was collected and presented
- 9:20Speaker 5: in abundance to the FDA, the FDA initially in twenty
- 9:25Speaker 5: twenty one lifted that in person dispensing requirement for the
- 9:29Speaker 5: remainder of the pandemic, and then ultimately lifted it permanently
- 9:33Speaker 5: in January of twenty twenty three. Again, the plaintiffs in
- 9:38Speaker 5: this case are making an argument that somehow that is
- 9:42Speaker 5: not safe, that somehow the FDA overlooked some kind of
- 9:48Speaker 5: study which it did not, and that therefore that restriction
- 9:52Speaker 5: should be reimposed, that patients should no longer be permitted
- 9:56Speaker 5: to receive the drugs at home by mail from their
- 10:00Speaker 5: healthcare provider or from a certified mail order pharmacy. What
- 10:05Speaker 5: that means for many patients is that they will be
- 10:08Speaker 5: forced to travel hundreds of miles, but in some cases,
- 10:13Speaker 5: again for the sole purpose of picking up their pill.
- 10:16Speaker 5: They can still have a telehoalth visit with their provider.
- 10:19Speaker 5: They can still be assessed where eligible, where appropriate by
- 10:25Speaker 5: the healthcare provider, not in in person setting, but they
- 10:29Speaker 5: might still have to travel hundreds of miles again for
- 10:32Speaker 5: the sole purpose of picking up a pill and taking
- 10:35Speaker 5: it home and taking it there. There is absolutely no
- 10:39Speaker 5: scientific basis for reimposing these old restrictions that were in
- 10:43Speaker 5: place again prior to twenty sixteen and prior to twenty
- 10:47Speaker 5: twenty one.
- 10:49Speaker 2: So it sounds like there are a lot of options
- 10:50Speaker 2: for the Supreme Court, and coming up on the program,
- 10:53Speaker 2: we'll talk more about that and the challenge to the
- 10:56Speaker 2: abortion drugmath for pristone with Laurie Shaydon, a senior staff
- 10:59Speaker 2: attorney at the ACLU's Reproductive Freedom Project. Remember you can
- 11:03Speaker 2: always get the latest legal news by listening to our
- 11:05Speaker 2: Bloomberg Law podcast on Apple, Spotify, or wherever you get
- 11:09Speaker 2: your podcasts.
- 11:10Speaker 3: I'm Kimberly Robinson.
- 11:12Speaker 4: And I'm Lydio Wheeler. This is Bloomberg.
- 11:21Speaker 1: You're listening to the Bloomberg Law Podcast. Catch the program
- 11:24Speaker 1: weekdays at ten pm Eastern on Bloomberg Radio, the tune
- 11:28Speaker 1: in app, Bloomberg dot Com and the Bloomberg Business App.
- 11:31Speaker 1: You can also listen live on Amazon Alexa from our
- 11:33Speaker 1: flagship New York station, Just say Alexa, play Bloomberg eleven thirty.
- 11:40Speaker 4: I'm Kimberly Robinson and I'm Lydio Wheeler. We've been speaking
- 11:43Speaker 4: with the aslu's Lori Chaton. How about the court battle
- 11:46Speaker 4: over the abortion drug mifipristone, Laurie. I wanted to step
- 11:49Speaker 4: back and take stock of what the landscape is following
- 11:52Speaker 4: the Court's twenty twenty two decision in the Dobbs case.
- 11:56Speaker 4: You know, where the Supreme Court undid federal abortion rights
- 12:00Speaker 4: rolling back Row versus Wade. How have the states responded
- 12:03Speaker 4: to that decision?
- 12:05Speaker 5: Well, I think that it's fair to say that quite
- 12:08Speaker 5: a number of them have responded quite badly and in
- 12:10Speaker 5: a way that is incredibly harmful for their residents. We
- 12:14Speaker 5: have seen more than twenty states either ban or heavily
- 12:18Speaker 5: restrict abortion since the Dab's decision, and that just means
- 12:22Speaker 5: that for patients in those states, again, in order to
- 12:26Speaker 5: access abortion care, they'll be required to travel long, long
- 12:31Speaker 5: distances in order to access the critical healthcare that they need.
- 12:35Speaker 5: And for many that means that they won't get this
- 12:38Speaker 5: care at all, that to be forced to carry a
- 12:40Speaker 5: pregnancy to term against their will because they simply cannot
- 12:44Speaker 5: arrange the logistical make the logistical arrangements and the financial
- 12:49Speaker 5: arrangements and the personal life arrangements that are needed in
- 12:53Speaker 5: order to travel out of state and sometimes through multiple
- 12:56Speaker 5: states in order to access care. The other the other
- 13:01Speaker 5: thing that we're seeing is that quite a number of
- 13:04Speaker 5: states are passing laws to shore up and to bolster
- 13:08Speaker 5: protections for reproductive healthcare, protections for abortion care, to try
- 13:12Speaker 5: to help providers in their states ensure that they can
- 13:16Speaker 5: try to meet the demand for abortion care. But the demand,
- 13:20Speaker 5: make no mistakes, the demand is mighty, and there's been
- 13:23Speaker 5: just this huge influx of patients coming from banned states
- 13:27Speaker 5: to access care. What that means is that for patients,
- 13:31Speaker 5: even in states that do support abortion rights and that
- 13:35Speaker 5: do take steps to try to ensure access to abortion,
- 13:40Speaker 5: there are long delays in some cases for people seeking
- 13:44Speaker 5: abortion care. And in many cases we've seen actually since Dubbs,
- 13:48Speaker 5: pregnancy complications are increasing because patients aren't able to get
- 13:52Speaker 5: the care that they need. The other thing I want
- 13:55Speaker 5: to mention is that in some of these states that
- 13:58Speaker 5: are banning abortion, they are going to such extreme lengths
- 14:02Speaker 5: that patients aren't able to actually get basic obgan care
- 14:06Speaker 5: that they need. Patients who are pregnant and are facing
- 14:11Speaker 5: health threatening and life threatening complications aren't often being denied
- 14:15Speaker 5: that care, and they're being denied that care because their
- 14:18Speaker 5: healthcare providers are facing the risks of criminal prosecution if
- 14:23Speaker 5: they somehow draw the line wrong, if they somehow say, yes,
- 14:27Speaker 5: my patience is sick enough, and therefore I'm going to
- 14:30Speaker 5: treat them, and then they are facing the threat that
- 14:33Speaker 5: they'll be prosecuted. And the other impact that is really
- 14:37Speaker 5: has been really sad is seeing that in some of
- 14:40Speaker 5: these states. Idaho is a perfect example, maternity care is
- 14:44Speaker 5: just shutting down. Obgians are leaving the state. They're not
- 14:48Speaker 5: willing to practice under those circumstances, and frankly, hospitals are
- 14:53Speaker 5: shutting down their maternity practices, and so again we have
- 14:56Speaker 5: maternity deserts in places like Idaho, in places like Labama.
- 15:01Speaker 5: All of this is phenomenally harmful to pregnant people, and
- 15:05Speaker 5: it particularly impacts in a negative way those who are
- 15:09Speaker 5: already facing serious risks because of structual racism in our
- 15:16Speaker 5: healthcare systems already being denied access to healthcare, people who
- 15:19Speaker 5: are people of color, people who live with low income
- 15:22Speaker 5: people in rural communities. Frankly, even in some of the
- 15:26Speaker 5: rural communities in states that are more supportive Right teamique
- 15:31Speaker 5: access problems.
- 15:32Speaker 6: Right.
- 15:32Speaker 3: I wonder too.
- 15:33Speaker 2: One of the outcomes from the courts twenty twenty two
- 15:35Speaker 2: decisions in Dobbs, at least n's anticipated by the justices
- 15:39Speaker 2: in the majority, was that they were going to return
- 15:43Speaker 2: this issue of abortion back over to elected officials instead
- 15:47Speaker 2: of to you know, unelected judges. But this methh of
- 15:50Speaker 2: pristone case that we've been talking about seems to sort
- 15:52Speaker 2: of fly in the face of that.
- 15:53Speaker 3: Right.
- 15:54Speaker 2: I mean, the courts here are being asked to second
- 15:56Speaker 2: guests the decisions of you know, executive branch officials. So
- 16:01Speaker 2: what did the Supreme Court mean when it said the
- 16:03Speaker 2: issue was being turned back over to elected officials.
- 16:07Speaker 5: Well, that's a good question, because, as you note, the
- 16:10Speaker 5: myth ofpristone case is intended to try to remove from
- 16:16Speaker 5: the market this drug that's used in most abortions in
- 16:19Speaker 5: the country. That means remove it from the market in
- 16:23Speaker 5: Illinois and in New York and in California, and those
- 16:26Speaker 5: are all states, and there are many others that are
- 16:29Speaker 5: taking great steps to try to protect access. And yet
- 16:34Speaker 5: we have this lawsuit where these anti abortion doctors have
- 16:38Speaker 5: gone to an anti abortion judge to try to impose
- 16:43Speaker 5: a ruling that would affect quite negatively abortion care throughout
- 16:47Speaker 5: the entire country. And make the mistakes. This is about
- 16:50Speaker 5: anti abortion opponents trying to be an abortion nationwide. This
- 16:55Speaker 5: is just one step in their campaign to deny people
- 17:00Speaker 5: throughout this country abortion care, to deny people the ability
- 17:04Speaker 5: to make the medical decisions that are best for them
- 17:07Speaker 5: and their families.
- 17:09Speaker 4: So, Laurie, this case has already been up to the
- 17:11Speaker 4: Supreme Court once this year on an emergency request, and
- 17:14Speaker 4: the Justice has sort of put everything on hold while
- 17:16Speaker 4: the case makes its way through the judicial system. So
- 17:19Speaker 4: what's the status of these drugs and their availability right now?
- 17:24Speaker 5: Well, as a result of the stay that the Supreme
- 17:26Speaker 5: Court entered, nothing has changed in terms of the available
- 17:30Speaker 5: these the medication. So today, and I want to be
- 17:33Speaker 5: clear about this for the listeners, people can access the
- 17:36Speaker 5: medication abortion using methropristo today. There are no limits as
- 17:40Speaker 5: a result of this case. Having said, that the Fifth
- 17:44Speaker 5: Circuit Court of Appeals, which is the most conservative court
- 17:48Speaker 5: in the country, has entered in order that would impose
- 17:52Speaker 5: some of these quite severe old restrictions that the FDA
- 17:57Speaker 5: long ago concluded were not necessary, and that decision is
- 18:02Speaker 5: now before the Supreme Court. The Supreme Court is deciding
- 18:06Speaker 5: as we sit here, whether it will review that decision
- 18:11Speaker 5: from the Fifth Circuit Court of Appeals, whether it will
- 18:13Speaker 5: review the decision from the District Court and re examine
- 18:18Speaker 5: the FDA's approval of mitropristown. So there is a lot
- 18:22Speaker 5: at stake here. We are waiting to hear from the
- 18:25Speaker 5: Court to see whether it is going to take this
- 18:27Speaker 5: case and leave it stay in place, whether it's going
- 18:31Speaker 5: to deny review of this case and lift its stake,
- 18:34Speaker 5: or whether it will take some other kind of action.
- 18:38Speaker 2: You know, I wonder if you get the sense that
- 18:40Speaker 2: some of the justices are eager to hear another abortion
- 18:43Speaker 2: case so close to the Dabbs decision, or if you
- 18:47Speaker 2: think they would have been happy to let the issues
- 18:49Speaker 2: sort of percolate in the States for a bit longer,
- 18:53Speaker 2: but the Fifth Circuit's opinions may sort of force their hand.
- 18:57Speaker 5: Well, I think that that's probably right. I don't can't
- 19:00Speaker 5: obviously speak for what they want and what they feel,
- 19:03Speaker 5: but I would imagine that they aren't excited about ticking
- 19:06Speaker 5: up another abortion cases soon. But having said that, the
- 19:09Speaker 5: Fifth Circuit's opinion is just so extreme and it's so
- 19:13Speaker 5: beyond the pale that we know that at least five
- 19:16Speaker 5: justices voted to have this stay put in place, meaning
- 19:20Speaker 5: that it's holding the Fifth Circuit's decision in abeyance through
- 19:23Speaker 5: any type of review from the Supreme Court.
- 19:26Speaker 4: So, Lorie, what are the next steps and what do
- 19:29Speaker 4: you see happening with this case of the Supreme Court?
- 19:32Speaker 5: We, as I said, are waiting to hear whether the
- 19:35Speaker 5: Court is granting a writ of cercuai. If it does that,
- 19:39Speaker 5: it could go two ways. One is that it could
- 19:43Speaker 5: grant review of part of the case or to grant
- 19:47Speaker 5: review of the whole case. Because there are actually a
- 19:49Speaker 5: number of petitions that are pending. We would expect, based
- 19:54Speaker 5: on the stay that it entered last spring, that it
- 19:56Speaker 5: will keep that stay in place, that basically, unless it
- 19:59Speaker 5: says something different that day will remain in place, which
- 20:02Speaker 5: means there will be no change to the provision of
- 20:05Speaker 5: medication abortion and other care using mifropristone while the case
- 20:10Speaker 5: continues to make its way through briefing, and if they
- 20:13Speaker 5: grant her soon, that case should be able to be
- 20:17Speaker 5: briefed and fully argued and decided this term. But the
- 20:22Speaker 5: court doesn't have to. It's not there's no deadline for
- 20:25Speaker 5: it to decide whether to take a case, and it
- 20:28Speaker 5: can do something called relisting. It can keep deciding, It
- 20:31Speaker 5: can keep putting it back from conference to conference to
- 20:34Speaker 5: decide whether it will take the case. And if it
- 20:37Speaker 5: waits too much longer, then the case would not be
- 20:40Speaker 5: able to be decided this term.
- 20:42Speaker 2: All right, well, thanks to Laurie Chayton of the ACLUS
- 20:45Speaker 2: Reproductive Freedom Project.
- 20:46Speaker 3: Coming up next on the Bloomberg Law.
- 20:48Speaker 2: Show, we'll talk about the ongoing efforts to oust the
- 20:51Speaker 2: Federal Judiciary's oldest active judge.
- 20:54Speaker 3: I'm Kimberly Robinson and I'm Lydia Wheeler. This is Bloomberg.
- 21:05Speaker 1: You're listening to the Bloomberg Law Podcast. Catch us weekdays
- 21:08Speaker 1: at ten pm Easter on Bloomberg dot Com, the iHeartRadio app,
- 21:12Speaker 1: and the Bloomberg Business App, or listen on demand wherever
- 21:15Speaker 1: you get your podcast.
- 21:19Speaker 4: I'm Kimberly Robinson, and I'm Lydia Wheeler in for June Grasso.
- 21:23Speaker 4: Let's get now to that ongoing saga to remove the
- 21:25Speaker 4: Federal Judiciary's oldest active judge from the bench. Joining us
- 21:29Speaker 4: to discuss it all is Michael Shapiro, a senior reporter
- 21:32Speaker 4: at Bloomberg Law who writes about intellectual property litigation and
- 21:35Speaker 4: covers the Federal Circuit. So, Michael, thanks so much for
- 21:38Speaker 4: joining us.
- 21:39Speaker 6: Yeah, thanks for having me.
- 21:40Speaker 4: So can you start off by telling us why the
- 21:42Speaker 4: Federal Circuit Judge Pauline Newman has been suspended from taking
- 21:46Speaker 4: new cases. How was that decision made, and what exactly
- 21:50Speaker 4: happened there?
- 21:51Speaker 6: Sure, so you're both aware that Judge Newman was suspended,
- 21:56Speaker 6: but some people might fail to appreciate if they're not
- 21:59Speaker 6: following this really closely. She has been suspended a number
- 22:04Speaker 6: of different times under different legal authority. Some of those
- 22:08Speaker 6: suspensions have run concurrently, and I can get back to
- 22:11Speaker 6: that in a bit. But apparently kicked everything off were
- 22:15Speaker 6: two health related events. According to the chief Judge for
- 22:19Speaker 6: the Federal Circuit, Kimberly more Newman suffered some kind of
- 22:22Speaker 6: a cardiac event back in twenty one this summer that
- 22:28Speaker 6: was followed by an alleged fainting spell that she had
- 22:31Speaker 6: after an horror argument session that was held in twenty
- 22:34Speaker 6: twenty two. Newman has denied both of those things, at
- 22:38Speaker 6: least in the way that they're described by Moore. So
- 22:42Speaker 6: exactly what happened there is still a little bit hazy.
- 22:45Speaker 6: But by March of twenty twenty three, Judge Moore has
- 22:49Speaker 6: started an investigation into Judge Newman. She's apparently heard from
- 22:55Speaker 6: court staff judges some combination of the two. At this point,
- 23:00Speaker 6: Newman might be suffering from quote, impairment of cognitive abilities unquote,
- 23:05Speaker 6: and that sort of goes to things like attention, focus,
- 23:09Speaker 6: and memory. More says at this point that Newman was
- 23:14Speaker 6: routinely making statements in open court and during deliberative proceedings
- 23:18Speaker 6: demonstrated a lack of awareness over the issues in her cases.
- 23:23Speaker 2: So we know that Judge Newman is challenging the suspension
- 23:27Speaker 2: or some of the suspensions wherever we are in that process.
- 23:31Speaker 3: Who did she sue and what is she arguing in
- 23:33Speaker 3: the lawsuit?
- 23:34Speaker 6: Sure? Well, yeah, just to be clear, she has disputed
- 23:39Speaker 6: a lot of the facts of this case. She's done
- 23:42Speaker 6: that there's kind of an administrative process that's going on.
- 23:46Speaker 6: And at the same time she followed this lawsuit against
- 23:48Speaker 6: her colleagues, she has said, you know, I'm one hundred
- 23:51Speaker 6: percent fit to be a judge. I can do this
- 23:55Speaker 6: job for a few more years. And she thinks her
- 23:58Speaker 6: colleagues are motivated not by concerns about her fitness, but
- 24:02Speaker 6: that she's independent and she's a dissenter on the court.
- 24:06Speaker 6: So there is this kind of administrative court process. What's
- 24:11Speaker 6: much rarer is for a judge who is being investigated
- 24:14Speaker 6: for some kind of misconduct or disability to go outside
- 24:18Speaker 6: of that system and sue. But that's exactly what Newman
- 24:22Speaker 6: has done here. She is, if nothing else, kind of
- 24:28Speaker 6: fierce and independent, and so perhaps it's in keeping with
- 24:32Speaker 6: that character that she is really taking an aggressive approach.
- 24:38Speaker 6: But she went ahead and she sued judges that were
- 24:42Speaker 6: on a special investigative committee that looked into the complaint
- 24:46Speaker 6: of dislleged disability. She did that in the district of
- 24:50Speaker 6: the DC. And so she is suing her colleagues basically
- 24:56Speaker 6: trying to get reinstated and making arguments about the statute
- 25:01Speaker 6: under which she is being investigated, as well as the
- 25:04Speaker 6: manner in which that investigation was carried out.
- 25:07Speaker 4: So, Michael, can you back up a little bit and
- 25:08Speaker 4: give us some background both on Judge Newman and the
- 25:11Speaker 4: Federal Circuit Court. Just remind our listeners, what are the
- 25:14Speaker 4: types of cases at this court? Here is most often?
- 25:16Speaker 6: Yeah, I can, and sort of the story of Judge
- 25:20Speaker 6: Newman's time as a judge and the Federal Circuit start
- 25:23Speaker 6: around the same time. She was the first presidential appointment
- 25:27Speaker 6: to this court called the Federal Circuit. The Federal Circuit
- 25:31Speaker 6: is a specialized appellate court and it has exclusive jurisdiction.
- 25:35Speaker 6: There were several real niche categories of law, and those
- 25:38Speaker 6: included government contract disputes, veterans benefits cases, and importantly to
- 25:44Speaker 6: Judge Newman, patents. The court was formed back in nineteen
- 25:49Speaker 6: eighty two. Back then, Newman, she's a chemist. She became
- 25:53Speaker 6: a lawyer. She became a big patent lawyer at a
- 25:56Speaker 6: company called FMC, which made pesticides, among other things. And
- 26:01Speaker 6: she was on an advisory board that said, you know,
- 26:04Speaker 6: there should be a specialized patent appeals court. That court
- 26:09Speaker 6: was created in nineteen eighty two as the Federal Circuit,
- 26:12Speaker 6: and two years later she was appointed by Ronald Reagan
- 26:15Speaker 6: to that court.
- 26:17Speaker 2: So it seems to me that it's got to be
- 26:19Speaker 2: pretty awkward for these colleagues on the bench to be fighting.
- 26:23Speaker 2: How have Judge Newman's colleagues responded to the lawsuit and
- 26:27Speaker 2: how does Judge Newman feel about the case?
- 26:30Speaker 3: I mean, has it created any tension on the bench?
- 26:33Speaker 6: Well, let me yeah, let me start with our colleagues.
- 26:37Speaker 6: They're all members of this judicial council. Every appellate every
- 26:42Speaker 6: circuit court and the district courts within it have what
- 26:45Speaker 6: are called judicial councils and they get tasked, among other things,
- 26:50Speaker 6: with disability and misconduct investigations. So for the Federal Circuit,
- 26:56Speaker 6: this specialized appellate court, the active members are the judicial council.
- 27:00Speaker 6: And so she is suing them and they suspended her,
- 27:06Speaker 6: so she's also and they did that because she's not
- 27:10Speaker 6: cooperating with the investigation. They want her to sit for
- 27:13Speaker 6: neurological testing with their choice of a doctor, and she
- 27:17Speaker 6: hasn't done that. But we don't really know what individual
- 27:20Speaker 6: judges on that court we're also kind of members of
- 27:23Speaker 6: this council have said, except through these formal filings. They're
- 27:31Speaker 6: represented by the Department of Justice and her lawsuit challenging
- 27:35Speaker 6: the suspension and investigation. So we get to see those briefs,
- 27:40Speaker 6: but as far as would have, individual judges said they
- 27:44Speaker 6: haven't spoken publicly. Newman, however, has spoken publicly many times.
- 27:51Speaker 6: When these investigations happen. They happened informally and quietly, but
- 27:56Speaker 6: she felt like there was an injustice here, and her
- 27:59Speaker 6: and her lawyers filed a public lawsuit for one thing,
- 28:03Speaker 6: but also talked about their dispute of what's being alleged
- 28:07Speaker 6: against her.
- 28:09Speaker 4: Michael, didn't the federal try to resolve this issue informally
- 28:13Speaker 4: and what did that look like and how did it
- 28:16Speaker 4: escalate to where we are now?
- 28:18Speaker 6: Yeah, well, I can say that, like many of these
- 28:21Speaker 6: disability investigations, you don't hear about them, even if they're disputed.
- 28:26Speaker 6: That that happens sort of in this internal process through
- 28:30Speaker 6: the courts, and maybe at the end of that you
- 28:33Speaker 6: see sort of a document with people's initials that talk
- 28:36Speaker 6: about what was alleged, but you don't even know the judge.
- 28:42Speaker 6: That sort of internal process had started, and at a
- 28:46Speaker 6: certain point the press started hearing from supporters of the
- 28:50Speaker 6: judge that she was being targeted an investigation, a lawsuit
- 28:57Speaker 6: has then filed by Judge Newman, and she did some interviews,
- 29:02Speaker 6: so it became public. Whether it would have been carried
- 29:08Speaker 6: out behind the scenes, that I don't know, but ultimately
- 29:11Speaker 6: the court may have felt like they kind of had
- 29:14Speaker 6: to tell their side publicly since the counter arguments were
- 29:18Speaker 6: being aired publicly, and they posted a fair bit of
- 29:21Speaker 6: information from the investigation and the internal case on the
- 29:25Speaker 6: court's website, which I'm told is kind of unheard of.
- 29:28Speaker 2: And so, Michael, a couple of times you've hinted at
- 29:32Speaker 2: this sort of internal process that can go on. Is
- 29:35Speaker 2: there are there a set of rules or process that
- 29:38Speaker 2: goes on when there's a situation for whatever regent reason,
- 29:42Speaker 2: that a judge can no longer perform their duties.
- 29:45Speaker 6: Yeah, there absolutely is a set of rules. There was
- 29:49Speaker 6: a statute passed in nineteen eighty called the Judicial Conduct
- 29:52Speaker 6: and Disability Act, and it sort of steps out its
- 29:54Speaker 6: framework and courts can investigate complaints against judges that can
- 29:59Speaker 6: be for misconducts like the name of the statute suggests, bribery,
- 30:06Speaker 6: conflicts of interests, judges abusing their staff, or something along
- 30:11Speaker 6: those lines. But it also has a disability component to it.
- 30:16Speaker 6: So if there's allegations that somebody's not well but as
- 30:20Speaker 6: serving as a judge, that can be investigated too. Those
- 30:25Speaker 6: investigations get carried out by these regional circuit courts themselves
- 30:31Speaker 6: or by the Federal Circuit in DC, and there's an
- 30:35Speaker 6: appeals process, but that's not a traditional court. It's to
- 30:39Speaker 6: the Judicial Conference and that's sort of the policy making
- 30:43Speaker 6: board for the federal court system. By John Just Chief
- 30:47Speaker 6: Justice John Roberts.
- 30:49Speaker 2: Michael, have you ever heard of anything playing out like
- 30:52Speaker 2: this so publicly? I mean, or is this just really
- 30:56Speaker 2: unprecedented at this point?
- 30:59Speaker 6: You know, there are experts in the Juditial Conduct and
- 31:03Speaker 6: Disability Act and they say, really, it's unusual to have
- 31:09Speaker 6: such a public dispute. There's not a lot of case
- 31:13Speaker 6: law over how the Judicial Conduct and Disability Act works
- 31:17Speaker 6: for that reason. So it's sort of interesting and in
- 31:20Speaker 6: an academic way that there's a lawsuit and there's all
- 31:25Speaker 6: this public discussion about it. But yeah, the word you
- 31:29Speaker 6: just hear how acceptually rare it is have it playing
- 31:33Speaker 6: out publicly, especially on a disability matter, where you know
- 31:37Speaker 6: that gets into somewhat sensitive questions about health and for
- 31:41Speaker 6: the most part, you know, we think about those things
- 31:44Speaker 6: being somewhat private.
- 31:46Speaker 4: So where does this case stand now? Is Judge Newman
- 31:48Speaker 4: hearing cases on the bench?
- 31:50Speaker 3: Still?
- 31:51Speaker 4: Is she is?
- 31:52Speaker 6: She?
- 31:53Speaker 3: Is she being reinstated? Can you kind of give us
- 31:55Speaker 3: the way of the land?
- 31:56Speaker 6: Sure? Against Judge Newman's will, she does not have cases anymore.
- 32:03Speaker 6: She was allowed to continue on in the cases that
- 32:07Speaker 6: she had, but at a certain point in the investigation
- 32:11Speaker 6: she was suspended from getting new cases. That's what she's
- 32:15Speaker 6: been challenging in her lawsuit. And then in September she
- 32:20Speaker 6: was suspended for a year for her alleged refusal to
- 32:24Speaker 6: cooperate with the investigation itself. So she doesn't have cases.
- 32:31Speaker 6: She has been going to patent law events and she's
- 32:37Speaker 6: really has this celebrated career and a lot of a
- 32:39Speaker 6: lot of very public backers who are fond of her.
- 32:44Speaker 6: But at this point she hasn't had a new case
- 32:47Speaker 6: in a while, and.
- 32:48Speaker 2: So wonder sort of what's next in this saga? I mean,
- 32:52Speaker 2: what do you expect to happen, you know, either publicly
- 32:55Speaker 2: or privately after this?
- 32:58Speaker 6: Yeah, well, most of the briefing is done to the
- 33:03Speaker 6: District Court Judge Christopher Cooper in DC. They have briefed
- 33:08Speaker 6: of this motion to intervene and emotion to dismiss or
- 33:11Speaker 6: excuse me that emotion to intervene, but an injunction that
- 33:15Speaker 6: Judge Newman is seeking as well as her colleagues effort
- 33:18Speaker 6: to dismiss her case. There is one more case deadline
- 33:23Speaker 6: this week, and then that will be ripe for Judge
- 33:26Speaker 6: to either decide whether the lawsuit could go forward or
- 33:29Speaker 6: whether something has to be done to somehow give her
- 33:33Speaker 6: some kind of duties back as a judge. Parallel to that,
- 33:38Speaker 6: there's this kind of more internal process at the Judicial
- 33:42Speaker 6: Conference where Judge Newman is also fighting the suspension, the
- 33:47Speaker 6: ultimate suspension that was issued in her case. They meet,
- 33:51Speaker 6: they convene like twice a year, the judges who sit
- 33:54Speaker 6: on this special committee of the Judicial Conference, and they
- 33:59Speaker 6: don't to do much publicly except they eventually will issue
- 34:04Speaker 6: decisions at the very end of their process. So that's
- 34:07Speaker 6: that's tough to predict the timing of. But those two
- 34:10Speaker 6: things are still both sitting out there, Michael.
- 34:13Speaker 4: Judge Newman is correct me if I'm wrong ninety six
- 34:16Speaker 4: years old. You know, some people might look at that
- 34:18Speaker 4: and say, why not just you know, call it a day,
- 34:21Speaker 4: and you had a good career and be done with it.
- 34:25Speaker 4: What does Judge Newman say too, I'm sure what she's
- 34:27Speaker 4: hearing are some of those criticisms.
- 34:29Speaker 6: She says that she is in good shape and she
- 34:33Speaker 6: thinks that what this court does, what she does is
- 34:35Speaker 6: a judge, is really important. She is She has a
- 34:38Speaker 6: voice and a voice that you know should be part
- 34:41Speaker 6: of the process. She is not the only older judge
- 34:47Speaker 6: on this court. And I think she probably would say,
- 34:50Speaker 6: although I don't want to speculate that if she really
- 34:54Speaker 6: didn't think she was well, she wouldn't do it. But
- 34:56Speaker 6: she doesn't. She thinks that it's it's kind of a
- 35:00Speaker 6: concocted case and that she's judging just like she was.
- 35:04Speaker 2: Well, that's Bloomberg Laws Menkel Shapiro, and that does it
- 35:07Speaker 2: for this edition of The Bloomberg Law Show.
- 35:10Speaker 3: I'm Kimberly Robinson and.
- 35:11Speaker 4: I'm Lydia Wheeler.
- 35:13Speaker 3: Stay with us.
- 35:13Speaker 4: Top stories and global business headlines are coming up right now.